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Mouse cortical development relies heavily on a delicate balance between neurogenesis
and gliogenesis. The lateral ventricular zone produces different classes of excitatory
pyramidal cells until just before birth, when the production of astroglia begins to prevail.
Epigenetic control of this fate shift is of critical importance and chromatin regulatory
elements driving neuronal or astroglial development play an vital role. Different classes
of chromatin binding proteins orchestrate the transcriptional repression of neuronal-
specific genes, while allowing for the activation of astrocyte-specific genes. Through
proteomic analysis of embryonic neural progenitor cells (NPCs) our group had previously
identified high mobility group B2 (HMGB2), a chromatin protein dynamically expressed
throughout embryonic development. In the current study using cultures of perinatal
NPCs from HMGB2+/+ and HMGB2−/− mice we discovered that vital elements of
the polycomb group (PcG) epigenetic complexes polycomb repressive complexes 1
and 2 (PRC1/2) were downregulated during the differentiation process of HMGB2-
null NPCs. These epigenetic changes led to downstream changes in specific histone
modification levels, specifically the trimethylation of H3K27, and a subsequent shift
in the perinatal neurogenesis to gliogenesis fate transition. Collectively these results
demonstrate that chromatin binding proteins, such as HMGB2, can have significant
effects on the epigenetic landscape of perinatal neural stem/progenitor cells.
Keywords: HMGB2, histone modification, postnatal neurogenesis, epigenetics, chromatin
INTRODUCTION
Neural stem/progenitor cells (NSPCs) persist in discrete areas of the postnatal mouse brain
(Abraham et al., 2013a). In the ventricular zone (VZ) and sub-ventricular zone (SVZ) of the
lateral ventricles, NSPCs proceed through sustained waves of neurogenesis (∼E10–E17.5) and
gliogenesis (∼E17.5–p10). These peaks of differentiation are not mutually exclusive: a small glial
component is produced in the embryonic period, and a small neuronal component is generated
in the early postnatal period. There is, however, a delicate and time precise balance that has to
be maintained—from the proper neuronal lamination of the cerebral cortex to the functional
integration of astrocytes and myelinating oligodendrocytes into the parenchymal tissue (Abraham
et al., 2013b).
Cortical neurogenesis (∼E10–E17.5) proceeds through a highly stereotyped cascade, whereby
radial glial fibers serve as a migratory scaffold for the inside out lamination of the cortical plate
(Cao et al., 2014). These bipolar progenitors extend their arbors to make contact with the glia
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limitans dorsally, and the VZ ventrally (Abraham et al.,
2013a). Radial glial endfeet therefore have extensive access
to signals from the meninges, as well as the cerebrospinal
fluid in the embryonic lateral ventricles. As neurogenesis
begins to wane toward the end of the embryonic period, this
pool of VZ progenitors undergoes a genetic fate switch—
giving rise to three primary brain-derived glial subtypes: (1)
astrocytes, (2) oligodendrocytes, (3) NG2+ cells (Corley and
Kroll, 2015). Postnatally, NSPCs retract their apical fibers from
the pial surface, and become restricted to VZ/SVZ, where
they are supported by a vast plexus of blood vessels, all the
while maintaining their ventricular contacts (Decoville et al.,
2001).
Specific genetic programs serve to underpin cell fate
transitions in the brain, such as the perinatal shift from
cortical neurogenesis to gliogenesis. Polycomb group (PcG) and
trithorax group (TrxG) proteins are well known epigenetic
mediators and play key roles in chromatin dynamics during
this period (Déjardin et al., 2005). First characterized in the
Drosophila embryo, they are critical in patterning the body
plan, as they bind to polycomb responsive elements (PREs)
to mediate their modulatory effects (Egan et al., 2013). Many
proteins are associated with and contribute to PcG-modulated
transcriptional regulation, and they are subdivided into two
complexes in the mouse, polycomb repressive complex 1 (PRC1)
and polycomb repressive complex 2 (PRC2). The mammalian
PRC2 includes three core proteins critical for gene repression:
enhancer of zeste 2 (EZH2), embryonic ectoderm development
(EED), and suppressor of zeste 12 (SUZ12) (Gabellini et al.,
2002)—a complex primarily involved in catalyzing the mono-,
di-, and tri-methylation of histone H3K27 (Gruber et al., 2011;
Gonzales-Roybal and Lim, 2013). Combinatorial activity of PcG
and TrxG in stem and progenitor cells regulates cell-type-
specific fate acquisition and differentiation reversibly through
the co-modification of gene promoters with both the “active”
H3K4me3 and “repressive” H3K27me3 modifications (He et al.,
2005).
After a shotgun proteomic screen of proliferating and
differentiating mouse embryonic NSPCs, we reported that
the chromatin architectural protein high mobility group B2
(HMGB2) was expressed with a high degree of temporal
variability—leading us to further probe its role in NSPC
dynamics (Hirabayashi et al., 2009; Hirabayashi and Gotoh,
2010). Dorsal switch protein 1 (DSP1), the Drosophila homolog
of HMGB2, has been classified as an enhancer of trithorax
and polycomb (a group of proteins modulating the activity of
PcG and TrxG) (Huang, 2014), and shown to form multimeric
complexes—serving as a prominent recruiter of polycomb
repressive factors to specific PREs during switches in cell
fate (Hwang et al., 2014). Knockdown of EED, a critical
component of PRC2, has been demonstrated to result in a
delayed neurogenic to gliogenic fate shift in E11.5 NSPCs
(Corley and Kroll, 2015). Given the epigenetic role played
by DSP1, we reasoned that the absence of expression of
HMGB2 in NSPCs may affect the time course and chromatin
characteristics of differentiated progeny (Jobe et al., 2012;
Kim and Kim, 2012; Hwang et al., 2014). We sought to
assess the functional contribution of murine HMGB2 in the
regulation of PcG proteins and consequent downstream effects
during the perinatal transition from cortical neurogenesis to
gliogenesis.
MATERIALS AND METHODS
Animals and Genotyping
All animal experiments performed have been approved by
and are in agreement with the guidelines of the Stony Brook
University (SBU) Institutional Animal Care and Use Committee
(IACUC). HMGB2 null breeding pairs on a C57BL/6 background
were obtained from Dr. Lorenza Ronfani (Core Facility for
Conditional Mutagenesis, San Raffaele Scientific Institute, Milan,
Italy). The HMGB2 deficient mouse line was created by
conventional gene targeting methods (Kokovay et al., 2010).
Due to the sterility of the HMGB2 homozygous null males
(Kokovay et al., 2010), two breeding strategies were employed
for the following experiments: heterozygous females were crossed
with heterozygous males or homozygous females crossed with
heterozygous males. In instances where Mendelian ratios did not
yield adequate numbers of HMGB2+/+ controls (e.g., the second
breeding scheme), age-matched controls were substituted from
non-transgenic C57BL/6 breeding. The HMGB2−/− animals are
smaller in size, but do not initially appear grossly phenotypically
different than wild-type animals.
Primary Adherent Monolayer Culture of
NSPCs
Pups ranging in age from postnatal day 0 to postnatal day 2
were used for all cell culture experiments. Brains were extracted
and placed in sterile Hank’s buffered salt solution (HBSS)
containing 2% glucose. From each hemisphere—olfactory bulbs,
hippocampi, midbrain, cerebellum, and meninges were dissected
away and discarded. The remaining brain regions, VZ, SVZ,
striatum, and minimal underlying cortex, were placed in 5 mL
of HBSS supplemented with 2% glucose. The tissue was
triturated in 1 mL of complete Neurocult neural progenitor
cells (NPC) Basal Proliferation Media with the addition of
20 ng/mL of recombinant human epidermal growth factor (rh
EGF), 10 ng/mL recombinant human basic fibroblast growth
factor (rh bFGF), 0.2% heparin, and 5% penicillin/streptomycin.
The tissue suspension was spun down at 1500 rpm at room
temperature. The subsequent tissue pellet was resuspended
in 200 µl of complete Neurocult NPC Basal Proliferation
Media with the addition of 20 ng/mL of rh EGF, 10 ng/mL
rh bFGF, 0.2% heparin, and 5% penicillin/streptomycin. The
tissue was further triturated with a pipette tip until a
uniform cell suspension was achieved. The cell suspension
was filtered through a 40 µm nylon mesh cell strainer and
plated on six-well plates precoated with 100 µg/mL poly-D-
lysine (PDL, 1 h), and 10 µg/mL laminin (4 h). Following
approximately 2–3 days of proliferative growth, the cells were
replated in precoated 60 mm tissue culture plates in complete
Neurocult differentiation media containing supplements and 5%
penicillin/streptomycin.
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Histone Extraction and Immunoblotting
Histones were obtained from cell culture lysates at various time
points primarily employing the method described in Kriegstein
and Alvarez-Buylla (2009). Briefly, cells were centrifuged at
room temperature at 300 g and the pellets cleaned with 10 mL
of sterile HBSS. The pellets were resuspended in 1 mL of
hypotonic lysis buffer (10 mM Tris–Cl pH 8.0, 1 mM KCl,
1.5 mM MgCl2, 1 mM dithiothreitol (DTT), protease and
phosphatase inhibitors; Kriegstein and Alvarez-Buylla, 2009)
and rotated at 4◦C for 30 min. Following this step, a nuclear
pellet was obtained by spinning the hypotonically dissociated
cells at 4◦C, 10,000 g for 10 min. Following this step the
NSPC nuclear pellet was resuspended in 400 µl of H2SO4
and rotated overnight at 4◦C. Nuclear debris was removed
by spinning the acid extracted preparation at 16,000 g for
10 min. A total of 132 µl of trichloroacetic acid was added
to the supernatant to a 33% final concentration to precipitate
the histones. A final spin step was used to pellet the purified
histones and two subsequent washes with ice-cold acetone cleared
away any remaining acid. The histones were dried for 20 min
at room temperature and resuspended in 100 µl of ddH2O.
Concentrations of purified histone proteins were obtained
via ImageJ densitometry measurements following 15% SDS-
PAGE and subsequent coomassie staining. Immunoblots utilized
the aforementioned percentage gels followed by transfer to
polyvinylidene difluoride membranes. The following antibodies
were used to probe for specific histone modifications: (1)
Tri-Methyl-Histone H3 (Lys27), Rabbit monoclonal antibody
(mAb) from Cell Signaling (#9733) at a concentration of
1:1000, (2) Di/Tri-Methyl-Histone H3 (Lys9), Mouse IgG1 mAb
from Cell Signaling (#5327) at a concentration of 1:2000,
(3) Tri-Methyl-Histone H3 (Lys4), Rabbit mAb from Cell
Signaling (#9751) at a concentration of 1:1000, (4) Ubiquityl-
Histone H2A (Lys119) Rabbit mAb from Cell Signaling
(#8240) at a concentration of 1:2000, (5) Anti-Histone H3
Rabbit polyclonal from Abcam (ab1791) at a concentration of
1:2500, (6) Anti-Histone H2A Rabbit polyclonal from GeneTex
(GTX129418).
Quantitative Real-Time PCR Arrays
The following Qiagen RT2 Profiler 84-gene arrays were utilized:
Mouse Polycomb & Trithorax Complexes (PAMM-506Z). The
arrays were loaded with cDNA reverse transcribed from RNA
which was obtained from 24-h differentiation cultures of
HMGB2+/+ and HMGB2−/− NSPCs. An Applied Biosystems
StepOnePlus Quantitative Real-Time PCR (qRT-PCR) machine
served as the PCR platform. Data were analyzed initially on the
Qiagen web-based analysis software followed by Microsoft Excel
(Supplementary Figure 1).
Quantitative Real-Time PCR
Total RNA was obtained from differentiating HMGB2+/+ and
HMGB2−/− NSPCs at days 1, 3, and 5. RNAbee (Amsbio)
was used for RNA extraction followed by purification via the
Qiagen RNeasy Mini Kit (74104). Subsequently cDNA was
reverse transcribed using the High-Capacity cDNA Reverse
Transcription Kit (Life Technologies—4368814). GAPDH was
used as housekeeping gene. For gene expression analysis, the
relative quantitation method was used (11Ct) with GAPDH
as an internal control. All primer sequences are listed in
Supplementary Table 1.
Immunocytochemistry/
Immunofluorescence
HMGB2+/+ and HMGB2−/− NSPCs were differentiated for
3 or 7 days in eight-well chamber slides (Fisher-Mediatech
177445) precoated with 100 µg/mL PDL (1 h), and 10 µg/mL
laminin (4 h) in a tissue culture incubator at 37◦C. HMGB2+/+
and HMGB2−/− NSPCs were differentiated for 3 or 7
days in eight-well chamber slides (Fisher-Mediatech 177445)
precoated with 100 µg/mL PDL (1 h), and 10 µg/mL laminin
(4 h) in a tissue culture incubator at 37◦C. Individual
chambers were blocked for 1 h with phosphate buffered saline
(PBS) containing 5% normal goat serum, 1% bovine serum
albumin (BSA), and 0.3% Triton-X100. Antibody solutions
were made up of PBS containing 1% BSA, and 0.03% Triton-
X100. Immunocytochemistry/immunofluorescence antibodies
are listed in Supplementary Table 2.
P1 wild-type (WT) and HMGB2 knock-out (KO) brains
were collected and passively fixed in 4% paraformaldehyde
(PFA), whereas p21 WT and KO brains were perfused with
4% PFA and postfixed with 4% PFA for 12 h. After fixation,
brains were put in 30% sucrose until they were no longer
floating, and then frozen in OCT via dry ice. Cryostat sectioning
at 20 µm thickness was done, and slides were stored in
−80◦C.
For staining, slides were allowed to get to room temperature,
and then washed in PBS. Blocking was done for 2 h at
room temperature with 5% serum and 0.3% Triton X-100.
Primary antibodies were diluted with 0.01% BSA and 0.3%
Triton X-100, and incubated at 4◦C overnight or 2 h at room
temperature. Slides were washed in PBS, and then incubated
with Alexa fluorophore secondary antibodies at 1:1000 dilution
for 1 h at room temperature. After another PBS wash, slides
were cover slipped with 4′,6-diamidino-2-phenylindole (DAPI)
Fluoromount.
Imaging was done on a SP8X Leica Confocal Microscope.
Images shown are 20 µm z-stacks.
Statistics
For comparisons between groups of two an unpaired, two-
tailed t-test was employed. For multiple comparisons within a
group a one-way ANOVA was used followed by either Holm–
Sidak multiple comparison post hoc analysis, or Bonferroni’s post
hoc multiple comparisons test. GraphPad Prism and Microsoft
Excel were used for all statistical analyses. A 95% confidence
interval is used for all figures indicating initial significance at
p < 0.05 marked by single asterisk “∗” and greater significance
at p < 0.01 marked by double asterisks “∗∗”. Standard error of
the mean (SEM) is the calculation underlying all graph error
bars, n refers to the number of biological replicates used in each
experiment.
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RESULTS
Polycomb Complex Genes
Downregulated in Differentiating NSPCs
from HMGB2−/− Mice
Monolayer NSPC cultures from HMGB2+/+ and HMGB2−/−
p0–p2 pups (isolated from primary dissections of SVZ) were
grown in media promoting cellular proliferation (bFGF and
rh EGF) until the plates were ∼85% confluent. The cells were
replated in 60 mm dishes containing differentiation media.
Following 24 h of differentiation the cells were harvested and
total RNA was extracted for 84-gene analysis via the Qiagen
qRT-PCR array system—specifically looking at genes encoding
key PcG and TrxG subunits (Supplementary Figure 1). In the
PcG and TrxG arrays key PRC1 and PRC2 subunits (EED,
SUZ12, CBX3, BMI1) were revealed to be downregulated in
the HMGB2−/− NSPCs following 1 day of differentiation
(Supplementary Figure 1). Although many other complex
macromolecular assemblies have built-in redundancies making
the elimination of one component tolerable, these key PcG
genes encode critical pieces of PRC1 and PRC2 complexes
(Gonzales-Roybal and Lim, 2013). To further refine the analysis
following the initially shallow Qiagen screen, we sought to
verify which of these components was downregulated at days 1
and 3 of NSPC differentiation using qRT-PCR. Primary NSPCs
were plated; after 2 days of proliferative growth they were
exposed to differentiation conditions through the removal of
growth factors from the media. RNA was extracted at 1 and 3
days following the induction of differentiation (Figure 1). Our
findings indicate that EED, an important member of PRC1 and
PRC2 is significantly downregulated by 50% in HMGB2−/−
NPCs at day 1 of differentiation (Figure 1A), and by 20% at
day 3 of differentiation (Figure 1B). The expression of the
FIGURE 1 | Assessment of genes downregulated in PcG and TrxG arrays via qRT-PCR. Following differentiation of NPCs for 1 and 3 days cDNA was
obtained for verification of gene expression patterns obtained via qRT-PCR arrays. Representative experimental timeline demonstrating 2 days of primary NPC
proliferation followed by differentiation of 1 and 3 days. (A) Time course of cell culture experiment. (B) qRT-PCR results from samples obtained at day 1 of
differentiation showing fold-change differences for four key PcG subunit complex genes, with EED showing significant downregulation in the HMGB2−/− samples as
compared with HMGB2+/+. (C) qRT-PCR results from samples obtained at day 3 of differentiation showing fold-change differences for four key PcG subunit
complex genes, with EED showing significant downregulation in the HMGB2−/− samples as compared with HMGB2+/+. n = 3 per genotype. ∗∗EED at day 1
p = 0.0038; ∗EED at day 3 p = 0.0109. To calculate fold change values the HMGB2+/+ levels for each gene were set to 1 (black bar).
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remainder of the genes examined, SUZ12, BMI1, and CBX3,
was not significantly modified (indicating that while the array
produced important leads, it would only be an initial step in the
analysis). Lower EED expression was evident in p1 HMGB2−/−
SVZ tissue compared to the expression in HMGB2+/+ animals,
although the difference was not statistically significant, possibly
reflecting EED protein stability (Supplementary Figure 2).
Collectively these results point to a critical role for the
chromatin protein HMGB2 in the dynamic regulation of EED,
a key polycomb complex component, and potentially the
expression of cell fate genes regulated by PcG.
Repressive Epigenetic Histone
Modifications in Differentiating
HMGB2-Null NSPCs
EED is a core component of the PRC2 complex catalyzing the
methylation of histone H3 at lysine 27 (K27; Lamiable et al.,
2010). The presence of tri-methylation on H3K27 can function
as signal to recruit PRC1 complexes to H3K27me3 marks,
and thus initiate the process of gene silencing and chromatin
condensation. EED also acts to stabilize H2A ubiquitin E3 ligase
activity (Gruber et al., 2011). It is therefore responsible for the
coordination of PRC1 and PRC2 activities, which are critical to
the repression of specific neuronal and astroglial genes (Gruber
et al., 2011; Lim and Alvarez-Buylla, 2014) and the onset of
stem cell differentiation (Lamiable et al., 2010). To examine
whether global levels of H3K27me3 were altered in HMGB2−/−
NSPCs we utilized the monolayer NSPC culture system from
which we acid-extracted histone proteins at days 1 and 3 of
differentiation (Figures 2A,B). H3K27me3 levels were visualized
using immunoblots; they remained the same 1 day following the
initiation of differentiation in the HMGB2+/+ and HMGB2−/−
NSPCs, however, they were significantly reduced at day 3 of
differentiation in the HMGB2−/− cultures (Figures 2C,D).
We also evaluated another repressive histone modification,
H3K9me3, which is laid down by a different epigenetic complex
that does not include EED (Margueron and Reinberg, 2011). No
changes were observed between HMGB2+/+ and HMGB2−/−
NPCs at differentiation (Supplementary Figure 3), suggesting
HMGB2 may be specifically involved in the regulation of
EED function. The mechanism regulating this putative negative
feedback loop remains to be elucidated.
Gliogenesis Is Perturbed in
Differentiating NSPCs from HMGB2−/−
Mice
To assess the differentiation properties of perinatal NSPCs
monolayer cultures were induced to differentiate in eight-
well chamber slides for 3 days and 7 days, followed by
immunostaining with cell-type specific antibodies. At day 3 of
differentiation significantly more GFAP+ astrocytes were present
in the HMGB2−/− wells compared to WT, while neuronal
populations, characterized by Tuj1+ staining, remained at near
undetectable levels (Figure 3). Oligodendrocyte differentiation
FIGURE 2 | Changes in repressive histone modifications in differentiating NSPCs. (A) Time course and outline of the experimental procedure. (B) Histone
proteins were purified with sulfuric acid (H2SO4) and precipitated using trichloroacetic acid; to quantify protein amounts proteins were electrophoresed on a
polyacrylamide gel and visualized with coomassie. M, signifies the molecular weight ladder. (C) Immunoblots employing antibodies against the histone modifications
H3K4me3 and H3K27me3, which are permissive and repressive, respectively. Total histone H3 represents the loading control. (D) Quantification of the histone
methylation western blot results showing reduction in H3K27me3 at 3 days of NPC differentiation in the HMGB2−/− NSPCs. n = 3–4 biological replicates per
genotype. ∗∗∗H3K27me3 from HMGB2−/− extracts at day 3 p = 0.0001. To calculate fold change values the HMGB2+/+ levels for each modified histone protein
over the relevant H3 levels were set to 1.
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FIGURE 3 | Ratios of neural and glial cells altered in HMGB2−/− SVZ cultures at day 3 of differentiation. NSPCs were cultured in eight-well chamber slides
with growth factor-free media and allowed to differentiate. Chamber slides from HMGB2+/+ and HMGB2−/− NPCs stained for the immature neuronal marker Tuj1,
all results represented as percentage of Tuj1+ (red) cells to all 4′,6-diamidino-2-phenylindole+ (DAPI+) (blue)nuclei. Chamber slides from HMGB2+/+ and
HMGB2−/− NPCs stained for the astrocyte marker GFAP, all results represented as percentage of GFAP+ (red) cells to all DAPI+ (blue) nuclei. n = 3 biological
replicates per genotype. Sixty cells were counted per biological replicate. ∗∗GFAP p = 0.0049. Scale bar = 150 µm.
was not assessed at this timepoint, as the differentiation process to
mature oligodendrocytes is not complete, and not all NG2+ cells
become oligodendrocytes. Interestingly at day 7 of differentiation
the percentage of Tuj1+ cells increased in the HMGB2−/−
wells (Figure 4). At this time point there was no difference in
the numbers of GFAP+ astrocytes between the two genotypes;
immunostaining for CC1 revealed a decrease in oligodendrocytes
in the HMGB2−/− wells. These data point to a possible role of
HMGB2 loss on the neurogenic to gliogenic fate transition that
occurs in perinatal NSPCs (Figure 4; Corley and Kroll, 2015).
In addition, our previous experimental findings in the adult
HMGB2−/− mouse brain corroborate these perturbed perinatal
cell fate transitions with a greater proportion of adult newborn
olfactory bulb interneurons present in the adult HMGB2−/−
animal (Hirabayashi et al., 2009). This also is supported by
the observation that there are apparent structural differences
in CNS anatomy in the HMGB2−/− mice. Fifty percent of the
animals (n= 14) displayed enlarged ventricles at 10 weeks of age,
while only 1 of 10 of HMGB2+/+ mice exhibited any detectable
ventricular enlargement at that age (Supplementary Figure 4).
Therefore, the effects of HMGB2 depletion may be additive
throughout development and into the adult mouse brain.
To further assess the differentiation properties of neural
stem cells (NSCs) lacking HMGB2, p1 and p21 HMGB2+/+
(WT) and HMGB2−/− (KO) brains were sectioned and imaged
(Figures 5A–C). As mentioned earlier, neurogenesis switches
to give rise to glial cells (Corley and Kroll, 2015). Glial
(PSA-NCAM+/NG2+) and neuronal (PSA-NCAM+/NG2−)
progenitors were counted along the SVZ, with p1 HMGB2 KO
mice having increased numbers of progenitors (Figure 5D).
There was no change in the immature glial cell population
(NG2+/PSA-NCAM−). Additionally, astrocytes were further
examined. Immature (Aldh1l1+) and mature (GFAP+) astrocytes
were evaluated in both the striatum and cortex (Figures 5B,C).
A trend toward an increase of immature astrocytes in p1 KO
was evident compared to WT, but by p21 there was no change
between WT and KO mice (Figure 5E). There was no difference
in the mature astrocyte population at p1, as GFAP expression is
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FIGURE 4 | Ratios of neural and glial cell altered in HMGB2−/− SVZ cultures at day 7 of differentiation. NPCs were cultured in eight-well chamber slides
with growth factor-free media and allowed to differentiate. Chamber slides from HMGB2+/+ and HMGB2−/− NPCs stained for the immature neuronal marker Tuj1,
all results represented as percentage of Tuj1+ (red) cells to all DAPI+ (blue) nuclei. Chamber slides from HMGB2+/+ and HMGB2−/− NPCs stained for the astrocyte
marker GFAP, all results represented as percentage of GFAP+ (red) cells to all DAPI+ (blue) nuclei. n = 3 biological replicates per genotype, 60 cells were counted per
biological replicate. Chamber slides from HMGB2+/+ and HMGB2−/− NPCs stained for the oligodendrocyte marker CC1, all results represented as percentage of
CC1+ (red) cells to all DAPI+ (blue) nuclei. n = 3 biological replicates per genotype. ∗∗Tuj1 p = 0.0054, ∗CC1 p = 0.0189. Scale bar = 150 µm, except for the CC1
images where the scale bar indicates 50 µm.
low and mature astrocytes are just now starting to form by p1
(Figure 5F; Mohn et al., 2008; Ming and Song, 2011). However,
by p21, there was a decrease in the numbers of mature astrocytes
in the medial striatum of KO mice compared to WT mice
(Figure 5F). These data further support a role of HMGB2 in
regulating the neurogenic/gliogenic fate, and support a prolonged
neurogenic phase.
DISCUSSION
In the experiments described in this study we identified a
potential role for HMGB2 in the epigenetic dynamics of NSPC
chromatin. We report that the germline loss of the HMGB2
gene and the resulting chromatin architectural protein that it
encodes contribute to a significant reduction in the expression
of the vital PcG gene EED, with concomitant reduction in
total H3K27me3 levels in NSPC histone lysates. These specific
genetic changes in the HMGB2−/− NSPC population may be
linked with the altered fate transitions observed in p0–p2 mouse
NSPCs when the proliferating cells are allowed to differentiate
into the three principal CNS cell types: neurons, astrocytes, and
oligodendrocytes (Obier et al., 2015). We do not think that
the phenotypes observed in the HMGB2−/− cells in our study
could be due to the fact that the HMGB2 ablation is global and
throughout development, as the cells do appear wild-type-like
in many of the parameters assessed. One parameter examined
was potential compensation by the other members of the HMGB
family. Immunohistochemical evaluation of HMGB1 revealed
a trend toward a modest upregulation of this protein in the
HMGB2−/− animals (Supplementary Figure 5), which was not
statistically significant. However, in support of our findings,
especially on the trimethylation levels of K27 on H3, a recent
report by Monte et al. (2016) described a similar decrease in
H3K27me3 when HMGB2 was knocked down in neonatal rat
ventricular myocytes using HMGB2 siRNA.
In the Drosophila model system DSP1/HMGB2 is critical
for recruitment of PcG complexes to specific PRE sites on
chromatin. DSP1 binding to PREs induces the recruitment of
PcG proteins and PcG-mediated silencing of certain active loci,
such as those responsible for the control of variegation. While
HMGB2 may also have a similar role to play in mammalian
systems, we report a novel negative feedback loop involved
with the control of PcG subunit gene expression (Hwang et al.,
2014). We and others have reported that HMGB2 interacts
with Oct4 dimers (Hirabayashi et al., 2009; Kriegstein and
Alvarez-Buylla, 2009). It has been speculated that instead of
only mediating PcG-repression, Hmgb2 may serve to maintain
a permissive chromatin environment at loci where Oct4 is
bound. The process may involve Akt activation thus linking it
to cell cycle progression, DNA damage repair, and the regulation
of cell fate transitions (Kriegstein and Alvarez-Buylla, 2009).
Although the analysis of chromatin modifications included all
gene loci (total lysates), EED has been shown to interact with the
promoters of specific pro-neuronal and pro-glial genes, inhibiting
the expression of their gene products at specific developmental
time-points (Ronfani et al., 2001; Shechter et al., 2007).
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FIGURE 5 | Effect of HMGB2 KO on brain cell populations in vivo. (A) Representative images of p1 HMGB2+/+ (WT) and HMGB2−/− (KO) SVZ, with
NestinGFP (green), PSA-NCAM (red), and NG2 (white). Scale bar = 100 µm. (B) Representative image of a p21 lateral ventricle, with DAPI (blue), the immature
astrocyte marker Aldh1l1 (red), and the mature astrocyte marker GFAP (white). Boxes outline areas where 63× images were taken blindly for quantification of
astrocytes for the lateral striatum, cortex, and medial striatum. Scale bar = 100 µm. (C) Representative images of the lateral striatum (L), cortex (C), and medial
striatum (M), with DAPI (blue), Aldh1l1 (red), and GFAP (white). Scale bar = 25 µm. (D) Quantification of oligodendrocyte precursor cells (OPCs), NPCs, and immature
glial cells in p1 WT and KO brains. OPCs were defined as PSA-NCAM+/NG2+, NPCs as PSA-NCAM+/NG2-, and immature glial cells as NG2+/PSA-NCAM-.
p = 0.0508 for OPCs, p = 0.1868 for NPCs, Student’s t-test. (E,F) Depict two 63× images taken for lateral striatum, cortex, and medial striatum, for a total of six
images per brain. (E) Quantification of Aldh1l1+ immature astrocytes. Aldh1l1+ cells from the different sections were added together and averaged across brains.
p = 0.1570 for p1. Student’s t-test. (F) Quantification of GFAP+ mature astrocytes. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, two-way ANOVA. n = 3 for all groups.
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Epigenetic modifiers can have profound effects on the fate
transitions of cells including NSPCs in the perinatal SVZ
(Shechter et al., 2007; Sparmann et al., 2013; Lim and Alvarez-
Buylla, 2014; Corley and Kroll, 2015). Germline deletion of
HMGB2 effects on the neurogenesis/gliogenesis fate transitions
were assessed in a cell culture NSPC monolayer model,
along with which molecular players potentially drive those
differences. We identified that the key PcG gene EED is
significantly downregulated during NSPC differentiation, with a
subsequent reduction in the repressive histone mark H3K27me3,
in agreement with a recent report in a different system.
EED is critically important for catalyzing this trimethylation
reaction. The changes were accompanied by greater numbers
of neuronal cells present in the HMGB2−/− cultures at day
7 of differentiation as compared with HMGB+/+. Reduction
of EED mRNA levels, and thereby the accompanying PcG
core subunit it encodes, has been associated with prolonged
neurogenesis and delayed gliogenesis (Shechter et al., 2007;
Abraham et al., 2013b; Steelman et al., 2016). Our results
support this correlation as we observed a plateau in the
numbers of cells differentiating toward astrocytes at day 7, and a
significant reduction in differentiation toward oligodendrocytes.
It is conceivable that the changes observed in the levels of
histone marks specifically catalyzed by the PRC1/2 complexes
come as a result of HMGB2 absence in the NSPCs, thereby
limiting the expression levels of core polycomb complex
genes.
Aberrant elongation of the neurogenic phase in mouse
cortical development can have many negative consequences,
including the improper lamination of cerebral cortex as well as
aberrant micro/macro circuit development. Such changes can be
clearly observed in various animal models of human congenital
microcephaly, such as the MCPH1-del mouse line—made to
recapitulate the neurodevelopmental disorder known as primary
microcephaly 1 (Steffen and Ringrose, 2014). Similarly, a large
increase in adulthood-evident hydrocephalus/ventriculomegaly
in the HMGB2−/− mouse brain may be indicative of mosaicism
in cortical development due to the germline loss of this
critical chromatin structural regulator. Our data suggest that the
elimination of HMGB2 in the perinatal NSPC cultures alters the
developmental timing—whereby the beginning of the gliogenic
phase may be shifted to later time points in the HMGB2−/−
cells allowing neurogenesis to persist even at later stages. With
gliogenesis starting later in the life of the animal, critical events
such as astrocytic integration into cortical circuits as well as
oligodendrocyte-mediated myelination of white matter tracts,
such as the corpus callosum, are delayed—resulting in stunted
cortical development overall. In fact in animals at 10 weeks of
age we found that GFAP staining of NestinGFP+HMGB2−/−
brain sections without ventriculomegaly revealed greater GFAP
staining in the SVZ compared to age-matched WT mice, although
the degree of this increase in GFAP staining in these HMGB2−/−
mice without ventriculomegaly was not significant (data not
shown). Therefore it seems reasonable to consider that HMGB2
absence in NSPCs, and the subsequent downregulation of EED
gene expression can have similar downstream effects on perinatal
cell fate choice. A number of other epigenetic factors could also
be contributors to this overall process, such as DNMT complexes
and TrxG elements, which together constitute major drivers of
mammalian neurogenesis (Testa, 2011).
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